Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis
出版年份 2013 全文链接
标题
Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis
作者
关键词
-
出版物
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 78, Issue 2, Pages 258-273
出版商
Wiley
发表日期
2013-12-11
DOI
10.1111/bcp.12306
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rosiglitazone is not associated with an increased risk of bladder cancer
- (2013) Chin-Hsiao Tseng Cancer Epidemiology
- Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies
- (2013) M. Ferwana et al. DIABETIC MEDICINE
- Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?
- (2013) Jean-Luc Faillie et al. DRUG SAFETY
- Risk of Bladder Cancer in Diabetic Patients Treated with Rosiglitazone or Pioglitazone: A Nested Case–Control Study
- (2013) Fei-Yuan Hsiao et al. DRUG SAFETY
- FDA panel advises easing restrictions on rosiglitazone
- (2013) M. E. Tucker BMJ-British Medical Journal
- Flip flop policy over pioglitazone licence causes media storm in India
- (2013) S. Bhaumik BMJ-British Medical Journal
- Pioglitazone and bladder cancer: a propensity score matched cohort study
- (2012) Li Wei et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis
- (2012) I. N. Colmers et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: A meta-analysis
- (2012) Zhaowei Zhu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes
- (2012) Kanta Fujimoto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
- (2012) A. Neumann et al. DIABETOLOGIA
- Stay vigilant: a glitazone (pioglitazone) can hide a glitazar!
- (2012) Dominique Hillaire-Buys et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Epidemiology and Risk Factors of Urothelial Bladder Cancer
- (2012) Maximilian Burger et al. EUROPEAN UROLOGY
- Examining the safety of PPAR agonists – current trends and future prospects
- (2012) Michele Bortolini et al. Expert Opinion On Drug Safety
- Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study
- (2012) Ronac Mamtani et al. JNCI-Journal of the National Cancer Institute
- The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
- (2012) L. Azoulay et al. BMJ-British Medical Journal
- The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
- (2012) Sun Ok Song et al. Diabetes & Metabolism Journal
- When to publish measures of disproportionality derived from spontaneous reporting databases?
- (2011) Anthonius de Boer BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pioglitazone and Bladder Cancer: A population-based study of Taiwanese
- (2011) C.-H. Tseng DIABETES CARE
- Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
- (2011) J. D. Lewis et al. DIABETES CARE
- Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
- (2011) C. Piccinni et al. DIABETES CARE
- Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan
- (2011) C.-H. Tseng DIABETOLOGIA
- Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
- (2011) Chia-Hsuin Chang et al. HEPATOLOGY
- Pioglitazone and bladder cancer
- (2011) Dominique Hillaire-Buys et al. LANCET
- Suppressive effects of acid-forming diet against the tumorigenic potential of pioglitazone hydrochloride in the urinary bladder of male rats
- (2011) Keiichiro Sato et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Bladder Cancer in 2010: How Far have We Come?
- (2010) B. L. Jacobs et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials
- (2010) P. D. Home et al. DIABETOLOGIA
- Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone
- (2010) David J. Graham et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes
- (2009) John Dormandy et al. DRUG SAFETY
- Liver Safety in Patients with Type 2 Diabetes Treated with Pioglitazone
- (2009) Keith G. Tolman et al. DRUG SAFETY
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Neoplastic and Non-neoplastic Changes in F-344 Rats Treated with Naveglitazar, a γ-Dominant PPAR α/γ Agonist
- (2009) Gerald G. Long et al. TOXICOLOGIC PATHOLOGY
- Effects of Pioglitazone, a Peroxisome Proliferator–Activated Receptor Gamma Agonist, on the Urine and Urothelium of the Rat
- (2009) Shugo Suzuki et al. TOXICOLOGICAL SCIENCES
- Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
- (2008) Y. K. Loke et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Rosiglitazone, a PPAR gamma agonist: Potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers
- (2008) Ronald A. Lubet et al. INTERNATIONAL JOURNAL OF CANCER
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Urothelial Carcinogenesis in the Urinary Bladder of Rats Treated with Naveglitazar, a γ-dominant PPAR α/γ Agonist: Lack of Evidence for Urolithiasis as an Inciting Event
- (2008) Gerald G. Long et al. TOXICOLOGIC PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started